您当前所在的位置:首页 > 产品中心 > 产品详细信息
58-22-0 分子结构
点击图片或这里关闭

(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

ChemBase编号:506
分子式:C19H28O2
平均质量:288.42442
单一同位素质量:288.20893014
SMILES和InChIs

SMILES:
O[C@@H]1[C@@]2([C@H]([C@H]3[C@@H]([C@@]4(C(=CC(=O)CC4)CC3)C)CC2)CC1)C
Canonical SMILES:
O=C1CC[C@]2(C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2O)C)C
InChI:
InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1
InChIKey:
MUMGGOZAMZWBJJ-DYKIIFRCSA-N

引用这个纪录

CBID:506 http://www.chembase.cn/molecule-506.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadec-6-en-5-one
IUPAC传统名
testosterone
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadec-6-en-5-one
商标名
Andriol
Andro
Andro 100
Andro L.A. 200
Androderm
Androgel
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Andrusol
Andryl 200
Beta Testosterone
CDB 111C
Cristerona T
Cristerone T
Delatest
Delatestryl
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
Everone 200
Geno-Cristaux Gremy
Homosteron
Homosterone
Libigel
Malerone
Malestrone
Malogen in Oil
Malogen, Aquaspension Injection
Mertestate
Metandren
Methyltestosterone
Neo-Hombreol F
Neo-Testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Primotest
Primoteston
Relibra
Scheinpharm Testone-Cyp
Striant
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testoviron
Testoviron Schering
Testoviron T
Testred
Testred Cypionate 200
Testrin-P.A
Testro Aq
Testrone
Testryl
Virilon
Virilon IM
Virormone
Virosterone
Androsorb
Androderm, Delatestryl
别名
睾酮 溶液
17β-羟基-3-氧代-4-雄甾烯
17β-羟基-4-雄甾烯-3-酮
4-雄甾烯-17β-醇-3-酮
反式-睾酮
睾酮
Testosterona [INN-Spanish]
Testosteronum [INN-Latin]
TES
Testosterone Hydrate
Testosterone Enanthate
Testosterone Cypionate
Testostosterone
Testosteron
Trans-Testosterone
Dea No. 4000
testosterone
Testosterone
Testosterone solution
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
Andropatch
Atmos
(17β)-17-Ηydroxyandrost-4-en-3-one
AndroGel
Androderm
Androlin
(+)-Testosterone
Testoderm
Testogel
Testolin
Testro AQ
Testrone
Virosterone
Testosterone
17β-Hydroxy-3-oxo-4-androstene
17β-Hydroxy-4-androsten-3-one
4-Androsten-17β-ol-3-one
CAS号
58-22-0
EC号
200-370-5
MDL号
MFCD00003654
Beilstein号
1915399
PubChem SID
46505691
24870573
160963969
24900279
24899970
PubChem CID
6013
CHEBI ID
17347
ATC码
G03BA03
CHEMBL
386630
Chemspider ID
5791
DrugBank ID
DB00624
IUPHAR配体索引
2858
KEGG ID
D00075
美国药典/FDA物质标识码
3XMK78S47O
维基百科标题
Testosterone

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 19.08686  质子受体
质子供体 LogD (pH = 5.5) 3.3654232 
LogD (pH = 7.4) 3.3654232  Log P 3.3654232 
摩尔折射率 84.4298 cm3 极化性 33.260063 Å3
极化表面积 37.3 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P 2.99  LOG S -3.94 
溶解度 3.33e-02 g/l 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
23.4 mg/L expand 查看数据来源
DMSO expand 查看数据来源
Ethanol expand 查看数据来源
Methanol expand 查看数据来源
外观
White Solid expand 查看数据来源
熔点
146-148°C expand 查看数据来源
155°C (311°F) expand 查看数据来源
闪点
41 °F expand 查看数据来源
5 °C expand 查看数据来源
比旋光度
+110.2° expand 查看数据来源
疏水性(logP)
3.6 expand 查看数据来源
临界点
-11080 kJ/mol expand 查看数据来源
保存条件
-20°C expand 查看数据来源
Controlled Substance, -20°C Freezer expand 查看数据来源
RTECS编号
XA3030000 expand 查看数据来源
欧盟危险性物质标志
易燃性(Flammable) 易燃性(Flammable) (F) expand 查看数据来源
有毒(Toxic) 有毒(Toxic) (T) expand 查看数据来源
联合国危险货物编号
2252 expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
3 expand 查看数据来源
联合国危险货物等级
3 expand 查看数据来源
联合国危险货物包装类别(PG)
2 expand 查看数据来源
危险公开号
45-60-61-11-19-20 expand 查看数据来源
45-63 expand 查看数据来源
安全公开号
53-16-45 expand 查看数据来源
53-36/37-45 expand 查看数据来源
GHS危险品标识
GHS02 expand 查看数据来源
GHS07 expand 查看数据来源
GHS08 expand 查看数据来源
GHS警示词
Danger expand 查看数据来源
GHS危险声明
H225-H332-H350-H360FD expand 查看数据来源
H350-H361 expand 查看数据来源
GHS警示性声明
P201-P210-P308 + P313 expand 查看数据来源
P201-P281-P308 + P313 expand 查看数据来源
个人保护装置
Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter expand 查看数据来源
Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges expand 查看数据来源
Eyeshields, Gloves, type P2 (EN 143) respirator cartridges expand 查看数据来源
RID/ADR
UN 2252 3/PG 2 expand 查看数据来源
欧盟补充危害声明
May form explosive peroxides. expand 查看数据来源
毒品管制信息
Home Office Schedule 4.2 expand 查看数据来源
USDEA Schedule III; Home Office Schedule 4.2; regulated under CDSA - not available from Sigma-Aldrich Canada expand 查看数据来源
USDEA Schedule IIIN; regulated under CDSA - not available from Sigma-Aldrich Canada expand 查看数据来源
保存温度
2-8°C expand 查看数据来源
给药途径
Intramuscular injection, transdermal (cream, gel, or patch), sub-'Q' pellet expand 查看数据来源
生物利用度
low (due to extensive first pass metabolism) expand 查看数据来源
排泄
Urine (90%), feces (6%) expand 查看数据来源
半衰期
2–4 h expand 查看数据来源
代谢
Liver, Testis and Prostate expand 查看数据来源
法定药品分级
Schedule III (USA)
Schedule IV (Canada)
expand 查看数据来源
妊娠期药物分类
X (USA), Teratogenic effects expand 查看数据来源
相关基因信息
human ... AR(367), EBP(10682), ESR1(2099), PGR(5241), SERPINA6(866), SHBG(6462)mouse ... Esr1(13982)rat ... Ar(24208), Esr1(24890), Nr3c1(24413), Nr3c2(25672), Pgr(25154) expand 查看数据来源
生物活性机理
Activity in many tissues appears to depend on reduction to dihydrotestosterone which binds to cytosolic receptor proteins expand 查看数据来源
Androgen expand 查看数据来源
Exogenous administration inhibits endogenous release via feedback inhibition of pituitary ICSH expand 查看数据来源
FSH antagonist. expand 查看数据来源
Gonadotropin antagonist expand 查看数据来源
High dose: spermatogenesis inhibitor expand 查看数据来源
ICSH antagonist expand 查看数据来源
The steroid receptor complex is transported to the nucleus where it initiates transcription events and cellular changes related to androgen action expand 查看数据来源
纯度
≥98% expand 查看数据来源
98% expand 查看数据来源
浓度
1.0 mg/mL±2% in 1,2-dimethoxyethane expand 查看数据来源
级别
drug standard expand 查看数据来源
VETRANAL™, analytical standard expand 查看数据来源
成盐信息
Free Base expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
适用性
cell culture tested expand 查看数据来源
生物来源
Constit. of human urine expand 查看数据来源
无菌消毒
γ-irradiated expand 查看数据来源
应用领域
Used in the treatment of male hypogonadism (transdermal administration) expand 查看数据来源
Empirical Formula (Hill Notation)
C19H28O2 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank Selleck Chemicals Selleck Chemicals Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich TRC TRC
DrugBank -  DB00624 external link
Item Information
Drug Groups approved; investigational
Description Testosterone is a steroid sex hormone found in both men and women. In men, testosterone is produced primarily by the Leydig (interstitial) cells of the testes when stimulated by luteinizing hormone (LH). It functions to stimulate spermatogenesis, promote physical and functional maturation of spermatozoa, maintain accessory organs of the male reproductive tract, support development of secondary sexual characteristics, stimulate growth and metabolism throughout the body and influence brain development by stimulating sexual behaviors and sexual drive. In women, testosterone is produced by the ovaries (25%), adrenals (25%) and via peripheral conversion from androstenedione (50%). Testerone in women functions to maintain libido and general wellbeing. Testosterone exerts a negative feedback mechanism on pituitary release of LH and follicle-stimulating hormone (FSH). Testosterone may be further converted to dihydrotestosterone or estradiol depending on the tissue.
Indication To be used as hormone replacement or substitution of diminished or absent endogenous testosterone. Use in males: For management of congenital or acquired hypogonadism, hypogonadism associated with HIV infection, and male climacteric (andopause). Use in females: For palliative treatment of androgen-responsive, advanced, inoperable, metastatis (skeletal) carcinoma of the breast in women who are 1-5 years postmenopausal; testosterone esters may be used in combination with estrogens in the management of moderate to severe vasomotor symptoms associated with menopause in women who do not respond to adequately to estrogen therapy alone.
Pharmacology Testosterone is a steroid hormone from the androgen group. Testosterone is primarily secreted from the testes of males. In females, it is produced in the ovaries, adrenal glands and by conversion of adrostenedione in the periphery. It is the principal male sex hormone and an anabolic steroid. In both males and females, it plays key roles in health and well-being. Examples include enhanced libido, energy, immune function, and protection against osteoporosis. On average, the adult male body produces about twenty times the amount of testosterone than an adult female's body does.
Toxicity Side effects include amnesia, anxiety, discolored hair, dizziness, dry skin, hirsutism, hostility, impaired urination, paresthesia, penis disorder, peripheral edema, sweating, and vasodilation.
Affected Organisms
Humans and other mammals
Biotransformation Testosterone is metabolized to 17-keto steroids through two different pathways. The major active metabolites are estradiol and dihydrotestosterone (DHT).
Absorption Approximately 10% of the testosterone dose applied on the skin surface is absorbed into systemic circulation
Half Life 10-100 minutes
Protein Binding 40% of testosterone in plasma is bound to sex hormone-binding globulin and 2% remains unbound and the rest is bound to albumin and other proteins.
Elimination About 90% of a dose of testosterone given intramuscularly is excreted in the urine as glucuronic and sulfuric acid conjugates of testosterone and its metabolites; about 6% of a dose is excreted in the feces, mostly in the unconjugated form.
References
Freeman ER, Bloom DA, McGuire EJ: A brief history of testosterone. J Urol. 2001 Feb;165(2):371-3. [Pubmed]
Hoberman JM, Yesalis CE: The history of synthetic testosterone. Sci Am. 1995 Feb;272(2):76-81. [Pubmed]
Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990 Oct 20;336(8721):955-9. [Pubmed]
External Links
Wikipedia
RxList
PDRhealth
Selleck Chemicals -  S2033 external link
Related research area: Endocrinology
Sigma Aldrich -  T1268 external link
Biochem/physiol Actions
睾丸分泌的睾酮在具有协调多种睾酮生物作用的目标组织中被转化为双氢睾酮。雄激素在胚胎形成过程中以及青春期引导男性表型的发育。
Sigma Aldrich -  T6147 external link
Biochem/physiol Actions
睾丸分泌的睾酮在具有协调多种睾酮生物作用的目标组织中被转化为双氢睾酮。雄激素在胚胎形成过程中以及青春期引导男性表型的发育。
Sigma Aldrich -  T1500 external link
Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
睾丸分泌的睾酮在具有协调多种睾酮生物作用的目标组织中被转化为双氢睾酮。雄激素在胚胎形成过程中以及青春期引导男性表型的发育。
Sigma Aldrich -  T5641 external link
Biochem/physiol Actions
睾丸分泌的睾酮在具有协调多种睾酮生物作用的目标组织中被转化为双氢睾酮。雄激素在胚胎形成过程中以及青春期引导男性表型的发育。
Sigma Aldrich -  46923 external link
Biochem/physiol Actions
睾丸分泌的睾酮在具有协调多种睾酮生物作用的目标组织中被转化为双氢睾酮。雄激素在胚胎形成过程中以及青春期引导男性表型的发育。
法律信息
VETRANAL 商标 Sigma-Aldrich Co. LLC
Toronto Research Chemicals -  T155000 external link
Testosterone, Principal hormone of the testes, produced by the interstitial cells. Major circulating androgen; converted by 5α-reductase in androgen-dependent target tissues to 5α-dehydrotestosterone which is required for normal male sexual differentiatio

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Freeman ER, Bloom DA, McGuire EJ: A brief history of testosterone. J Urol. 2001 Feb;165(2):371-3. Pubmed
  • Hoberman JM, Yesalis CE: The history of synthetic testosterone. Sci Am. 1995 Feb;272(2):76-81. Pubmed
  • Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990 Oct 20;336(8721):955-9. Pubmed
  • http://en.wikipedia.org/wiki/Testosterone
  • Kumar, R., et al.: Biol. Reprod., 65, 710 (1989)
  • McFarland, K., et al.: Science, 245, 494 (1989)
  • Heckert, L., et al.: Mol. Endocrinol., 12, 1499 (1989)
  • Themmen, A., et al.: Endocr. Rev. 21, 551 (1989)
  • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 52C, (ir)
  • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 2, 800B, (nmr)
  • Lampe, V., Ber., 1918, 51, 1347, (synth)
  • Srinivasan, K.R., J. Pharm. Pharmacol., 1953, 5, 448, (derivs)
  • Jentzsch, K. et al., Sci. Pharm., 1968, 36, 251; CA, 70, 90793h, (isol)
  • Sastry, B.S., Res. Ind., 1970, 15, 258; CA, 75, 75063e, (isol)
  • Kuroyagi, M. et al., Yakugaku Zasshi, 1970, 90, 1467; CA, 74, 61612a, (isol)
  • Dyrssen, D.W. et al., Anal. Chim. Acta, 1972, 60, 139, (detn, B)
  • Roughley, P.J. et al., J.C.S. Perkin 1, 1973, 2379-2388, (biosynth)
  • Karig, F., Dtsch. Apoth. -Ztg., 1975, 115, 325; CA, 83, 65372f, (derivs)
  • Quint, P. et al., Fresenius' Z. Anal. Chem., 1977, 285, 356; 1979, 295, 269, (detn, B)
  • Kashina, C. et al., Heterocycles, 1977, 7, 241, (synth)
  • Wahlstrom, B. et al., Acta Pharmacol. Toxicol., 1978, 43, 86, (metab)
  • Holder, G.M. et al., Xenobiotica, 1978, 8, 761, (metab)
  • Tonnesen, H.H. et al., Acta Chem. Scand., Ser. B, 1982, 36, 475, (cryst struct, bibl)
  • Cheng, K.L. et al., Handbook of Organic Analytical Reagents, CRC Press, Boca Raton, 1982, 511, (use)
  • Ammon, H.P.T. et al., Planta Med., 1991, 57, 1-7, (rev, pharmacol)
  • Jitoe, A. et al., J. Agric. Food Chem., 1992, 40, 1337-1340, (occur)
  • Encyclopedia of Food and Color Additives, (ed. Burdock, G.A.), CRC Press, 1997, 2856-2858
  • Khar, A. et al., FEBS Lett., 1999, 445, 165-168, (antitumour props)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle